Categories: Software

Pressly could be King, say investors OMERS, iNovia

Pressly founder Jeff Brenner. After a month-long beta period, iNovia Capital and OMERS Ventures have conferred $1.5 million on the Toronto-based mobile publishing platform
After a month-long beta period, iNovia Capital and OMERS Ventures have conferred $1.5 million on Toronto-based mobile publishing platform, Pressly, which converges online content into an “immersive” tablet and smartphone oriented experience for its clients. The money will be used to expand Pressly’s 16-strong Toronto staff, help with marketing efforts, and continue development of its product.

As brands struggle with developing content for HTML5, social media and mobile platforms, Pressly has specialized in content marketing strategy, inking deals with The Economist, The Toronto Star, and various Ziff Davis publications, as well as providing branded content services for Global 2000 companies, such as IBM and Toyota.

“We know brands and publishers are looking for a platform to amplify their message on mobile devices – which is a far cry from the keyboard and mouse world. Pressly absolutely nails it with this product,” said Karamdeep Nijjar, a Principal at iNovia Capital.

The cash injection arrives just as Pressly steps out of beta mode during which it worked with 500 testers. They’re now offering a 30-day free trial to the public, with business rates fluctuating between $199 and $499.

“At OMERS Ventures we invest in companies we believe can become global leaders. We think Pressly has huge potential due to its innovative products, strong management team and continuing market traction,” said Derek Smyth, Managing Director of OMERS Ventures.

Below: CEO Jeff Brenner explains how Pressly is moving publishers into the tablet era.

_________________

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Terry Dawes

Recent Posts

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

14 hours ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

16 hours ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

1 day ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

2 days ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

2 days ago